These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30115244)

  • 1. A Developmental Perspective of Dopaminergic Dysfunction in Tourette Syndrome.
    Dwyer JB
    Biol Psychiatry; 2018 Sep; 84(5):e33-e35. PubMed ID: 30115244
    [No Abstract]   [Full Text] [Related]  

  • 2. Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene.
    Müller-Vahl KR; Loeber G; Kotsiari A; Müller-Engling L; Frieling H
    J Psychiatr Res; 2017 Mar; 86():1-8. PubMed ID: 27883923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tourette syndrome. New aspects on pharmacological treatment].
    Aabech HS
    Tidsskr Nor Laegeforen; 1989 Mar; 109(9):961-3. PubMed ID: 2565050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional imaging of dopaminergic neurotransmission in Tourette syndrome.
    Segura B; Strafella AP
    Int Rev Neurobiol; 2013; 112():73-93. PubMed ID: 24295618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome.
    Brooks DJ; Turjanski N; Sawle GV; Playford ED; Lees AJ
    Adv Neurol; 1992; 58():227-31. PubMed ID: 1414627
    [No Abstract]   [Full Text] [Related]  

  • 6. Developmental perspective of the Gilles de la Tourette syndrome.
    Incagnoli T; Kane R
    Percept Mot Skills; 1983 Dec; 57(3 Pt 2):1271-81. PubMed ID: 6582444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcement learning and Tourette syndrome.
    Palminteri S; Pessiglione M
    Int Rev Neurobiol; 2013; 112():131-53. PubMed ID: 24295620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic and dopaminergic mechanisms in Gilles de la Tourette syndrome.
    Sweeney D; Pickar D; Redmond DE; Maas J
    Lancet; 1978 Apr; 1(8069):872. PubMed ID: 76814
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic and dopaminergic mechanisms in Tourette syndrome.
    Stahl SM; Berger PA
    Adv Neurol; 1982; 35():141-50. PubMed ID: 6959486
    [No Abstract]   [Full Text] [Related]  

  • 11. Bithalamical deep brain stimulation in tourette syndrome is associated with reduction in dopaminergic transmission.
    Vernaleken I; Kuhn J; Lenartz D; Raptis M; Huff W; Janouschek H; Neuner I; Schaefer WM; Gründer G; Sturm V
    Biol Psychiatry; 2009 Nov; 66(10):e15-7. PubMed ID: 19709645
    [No Abstract]   [Full Text] [Related]  

  • 12. Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome.
    Caligiore D; Mannella F; Arbib MA; Baldassarre G
    PLoS Comput Biol; 2017 Mar; 13(3):e1005395. PubMed ID: 28358814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tourette syndrome and comorbid pervasive developmental disorders.
    Burd L; Li Q; Kerbeshian J; Klug MG; Freeman RD
    J Child Neurol; 2009 Feb; 24(2):170-5. PubMed ID: 19182154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tourette syndrome. Genetics, neuroanatomy and neurotransmitters].
    Debes NM; Skov L; Hjalgrim H
    Ugeskr Laeger; 2008 Aug; 170(35):2695-700. PubMed ID: 18761860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients.
    Ferrari M; Termine C; Franciotta D; Castiglioni E; Pagani A; Lanzi G; Marino F; Lecchini S; Cosentino M; Balottin U
    J Psychiatr Res; 2008 Nov; 43(1):24-9. PubMed ID: 18329046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurobiology of Tourette Syndrome].
    Ünal D; Akdemir D
    Turk Psikiyatri Derg; 2016; 27(4):275-285. PubMed ID: 28046197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.
    Comings DE; Wu S; Chiu C; Ring RH; Gade R; Ahn C; MacMurray JP; Dietz G; Muhleman D
    Am J Med Genet; 1996 May; 67(3):264-88. PubMed ID: 8725745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.
    Wolf SS; Jones DW; Knable MB; Gorey JG; Lee KS; Hyde TM; Coppola R; Weinberger DR
    Science; 1996 Aug; 273(5279):1225-7. PubMed ID: 8703056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.